Bio-Rad introduces CFX Opus Dx real-time PCR detection systems for IVD use

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Opus 96 Dx System and the CFX Opus 384 Dx System, real-time PCR detection systems that have been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and that meet the CE-IVD requirement for IVD use in Europe. Both systems are also registered with regulatory bodies for IVD use in Singapore and Canada.

The CFX Opus 96 Dx System and the CFX Opus 384 Dx System are the latest additions to Bio-Rad’s portfolio of real-time PCR instruments. The systems offer accurate and precise quantification to improve assay development and workflow efficiencies and productivity for diagnostic testing and research. The CFX Opus 96 Dx Real-Time PCR System and the CFX Opus 384 Dx Real-Time PCR System are open systems that can multiplex up to five targets to provide efficient IVD assay development and testing. The systems provide precise quantification, improved thermal cycler performance, and the systems offer easy-to-use desktop management and analysis software with integrated security features.

We continue to see an increasing demand for real-time PCR systems that offer more efficient workflows and improved data management and analysis that meets regulatory requirements in IVD assay development and testing, and we’re pleased to introduce the CFX Opus Dx Detection Systems to meet these needs.”

Steven Blakely, Director for Gene Expression and Software Technology, Bio-Rad

“Both systems are robust and secure platforms that leverage Bio-Rad’s long-standing expertise in genomic tools to better serve both research and clinical diagnostic markets,” he added.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bio-Rad Laboratories. (2023, March 27). Bio-Rad introduces CFX Opus Dx real-time PCR detection systems for IVD use. News-Medical. Retrieved on June 24, 2024 from https://www.news-medical.net/news/20211025/Bio-Rad-introduces-CFX-Opus-Dx-real-time-PCR-detection-systems-for-IVD-use.aspx.

  • MLA

    Bio-Rad Laboratories. "Bio-Rad introduces CFX Opus Dx real-time PCR detection systems for IVD use". News-Medical. 24 June 2024. <https://www.news-medical.net/news/20211025/Bio-Rad-introduces-CFX-Opus-Dx-real-time-PCR-detection-systems-for-IVD-use.aspx>.

  • Chicago

    Bio-Rad Laboratories. "Bio-Rad introduces CFX Opus Dx real-time PCR detection systems for IVD use". News-Medical. https://www.news-medical.net/news/20211025/Bio-Rad-introduces-CFX-Opus-Dx-real-time-PCR-detection-systems-for-IVD-use.aspx. (accessed June 24, 2024).

  • Harvard

    Bio-Rad Laboratories. 2023. Bio-Rad introduces CFX Opus Dx real-time PCR detection systems for IVD use. News-Medical, viewed 24 June 2024, https://www.news-medical.net/news/20211025/Bio-Rad-introduces-CFX-Opus-Dx-real-time-PCR-detection-systems-for-IVD-use.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bio-Rad launches new isotype-specific secondary antibodies